Top HCP (Healthcare Professional) Panels in the United States for Pharma Research
Compare leading providers for HCP panels in the United States for pharmaceutical research in 2026 to protect verified data and high-quality clinical insights.
Quick answer
For large-scale, multi-methodological pharmaceutical tracking, IQVIA offers distinct depth; for specialized, verified physician qualitative and quantitative projects, Global Vox Populi and Sermo provide high-accuracy access; for agile, platform-driven consumer and professional insights, Dynata and Sago offer extensive reach.
Selecting the right partner for HCP panels in the United States requires balancing the need for deep, verified professional access against the complexities of modern pharma market research compliance. As pharmaceutical companies face increasing pressure to quantify treatment patterns and physician behavior, the quality of respondent data has become the single most significant factor in strategic decision-making.
This assessment examines the primary providers of HCP panels in the United States, evaluating them on their ability to maintain data integrity, verify credentials, and adhere to strict regulatory standards such as HIPAA and industry-specific codes. Whether your research objective involves brand health tracking, concept testing, or complex physician segmentation, identifying a provider that aligns with your specific therapeutic and methodological requirements is essential for project success in 2026.
Top HCP Panels in the United States for Pharma Research: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA | Large-scale pharmaceutical life science analytics | 86.0 |
| 2 | M3 Global Research | ISO-certified physician market research | 86.0 |
| 3 | Global Vox Populi | Verified physician and KOL research | 85.0 |
| 4 | Sermo | Peer-to-peer physician community insights | 83.0 |
| 5 | Ipsos Healthcare | Global brand health and market tracking | 79.5 |
| 6 | Sago | Hybrid qualitative and quantitative healthcare research | 79.0 |
| 7 | Dynata | Multi-modal data collection at scale | 77.5 |
| 8 | Toluna | AI-enhanced consumer and healthcare insights | 73.0 |
| 9 | Cint | Agile quantitative data collection | 66.5 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA | Physicians, pharmacists, wholesalers, payers | Internal professional databases and clinical records | Not stated on pages reviewed | Not published | Not published | Not published |
| M3 Global Research | Physicians, pharmacists, nurses, patients | Professional panel validation and industry training | ISO 20252, ISO 27001 | Not published | Not published | Not published |
| Global Vox Populi | Physicians, nurses, allied health, KOLs, patients | License and registration verification with rolling updates | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Not published | 174,360 healthcare professionals; 7,707 key opinion leaders; 197,240 nurses and allied health professionals (in the United States; Global Vox Populi panel records, Oct 2026) | Not published |
| Sermo | Physicians, nurses, NPs, PAs, pharmacists | Identity and professional credential verification | Not stated on pages reviewed | Not published | Not published | Not published |
| Ipsos Healthcare | Doctors, patients, consumers | Authenticated proprietary panels | Not stated on pages reviewed | Not published | Not published | Not published |
| Sago | Healthcare professionals, patients, consumers | SagoVerify and rigorous compliance processes | Not stated on pages reviewed | Not published | Not published | Not published |
| Dynata | Healthcare professionals, patients, caregivers | Multi-layered verification and quality score monitoring | Not stated on pages reviewed | Not published | Not published | Not published |
| Toluna | Healthcare professionals, consumers, decision-makers | Professional ID checks | Not stated on pages reviewed | Not published | Not published | Not published |
| Cint | Consumers, healthcare professionals, decision-makers | Multi-layered AI and machine learning defenses | SOC 2 Type I | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA | ● | – | – | ● | – | – |
| M3 Global Research | ● | ● | ● | ● | ● | ● |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| Sermo | ● | ● | – | ● | – | – |
| Ipsos Healthcare | ● | ● | ● | ● | ● | ● |
| Sago | ● | ● | – | ● | – | – |
| Dynata | ● | ● | – | ● | – | ● |
| Toluna | ● | ● | ● | ● | – | – |
| Cint | ● | ● | ● | ● | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their ability to deliver consistent, compliant, and verified healthcare professional data for sensitive pharmaceutical research applications.
| Criterion | Weight | What it means here |
|---|---|---|
| Sample Quality and Verification | 25 | This criterion measures the origin of respondents and the rigor of credentialing. Good providers use proprietary, owned panels with ongoing license validation rather than external exchanges. For pharmaceutical research in the United States, this makes sure that the physicians and specialists surveyed are authentic, active practitioners and not impersonators or automated bots. |
| Compliance, Certifications and Security | 20 | This evaluates adherence to ISO standards, HIPAA, and industry codes. A high score requires documented processes for adverse event reporting and patient data protection. In the United States, pharmaceutical research is highly regulated, and a provider must demonstrate a formal, audit-ready approach to maintaining participant privacy and ethical research practices. |
| Target Audience Reach | 15 | This assesses the ability to access specific, hard-to-reach niches, including rare-disease specialists or low-incidence physician groups. Effective panels must offer deep profiling data to avoid screening out relevant participants. High scores are awarded for providers that can reliably deliver representative samples for specialized therapeutic areas within the United States market. |
| Data Quality and Fraud Prevention | 10 | This measures technical defenses against survey fraud, including device fingerprinting, geo-location checks, and straight-lining detection. For pharma research, data quality is essential to avoid skewed results. A strong provider actively monitors response patterns in real-time, removing poor-quality completions before they contaminate the final dataset provided to the client. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This evaluates the diversity of research tools available, from simple online surveys to complex ethnography, focus groups, and in-depth interviews. A comprehensive provider supports both quantitative scale and qualitative depth, allowing researchers to choose the best method for the specific insight needed at each stage of a drug's lifecycle. |
| Client Service and Speed | 5 | This assesses the responsiveness of project management teams and the ability to meet tight timelines. In the fast-moving pharmaceutical sector, a provider that communicates clearly, manages project bottlenecks effectively, and provides proactive updates is essential. High scores reflect a culture of service that prioritizes accuracy alongside operational efficiency. |
| Pricing and Feasibility Transparency | 5 | This measures the clarity of feasibility estimates and cost structures. A transparent provider offers realistic expectations regarding sample availability and incidence rates before a project begins. This prevents mid-study delays or budget overruns, making sure that researchers can plan their pharmaceutical studies in the United States with confidence and budgetary predictability. |
Why these weights. In healthcare, a respondent who is not a verified professional or a genuine patient invalidates the study, so verification leads (25). Compliance follows at 20 because health data, HIPAA and adverse event reporting carry legal risk. Reach into specialties and conditions (15), fraud prevention and methods (10 each), service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: HCP panels in the United States
IQVIA: best for large-scale pharmaceutical life science analytics
Strongest fitSuited for large pharmaceutical organizations needing to bridge the gap between physician sentiment and real-world clinical data.
IQVIA is a global life sciences entity focused on accelerating innovation and commercial performance. In the United States, it provides market research as part of a larger network of clinical development and commercial execution solutions.
Its approach integrates internal HCP panels with massive datasets, including non-identified patient records. This allows for research that connects stated physician opinions with actual treatment patterns and market trends.
Scorecard: 86.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 86.0 |
Core services
- Clinical Market Research: Conducts studies to measure treatment patterns and commercial performance for pharmaceutical assets.
- Data Analytics: Uses petabytes of proprietary data to provide benchmarks and insights into market dynamics.
- Consulting Services: Offers strategic guidance on product launch, patient adherence, and commercial execution.
Strengths
- Data Integration: Connects survey insights with real-world, non-identified patient records and pharmacy data.
- Industry Scale: Uses extensive infrastructure to manage complex, end-to-end clinical and commercial research.
Innovation and technology
- AI-Powered Intelligence: Uses agentic AI and predictive models to simulate market outcomes and optimize clinical development.
Impact on businesses
- Asset Maximization: Helps pharma companies improve the probability of success in competitive environments.
Why it may fit your brief
IQVIA is ideal for high-level commercial strategy and large-scale tracking. Smaller, agile projects may find more cost-effective solutions with dedicated, independent research providers.
M3 Global Research: best for ISO-certified physician market research
Strongest fitBest for researchers requiring rigorous, ISO-certified data collection from a large, established physician panel.
M3 Global Research is a dedicated healthcare fieldwork firm that provides qualitative and quantitative solutions. It maintains a proprietary panel of physicians, pharmacists, and nurses focused on delivering actionable insights.
The firm emphasizes compliance and quality, holding ISO certifications that govern its panel management and data security. Its services are designed to meet the specific demands of pharmaceutical and medical device research.
Scorecard: 86.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | m3global.com (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 86.0 |
Core services
- Fieldwork Services: Provides end-to-end management of quantitative and qualitative healthcare research projects.
- HCP Panel Access: Offers access to a large proprietary panel of verified medical professionals.
- Methodological Support: Supports a range of remote and in-person methodologies for data collection.
Strengths
- Quality Standards: Holds ISO 20252 certification for its physician panel and ISO 27001 for information security.
- Panel Breadth: Operates one of the largest proprietary panels of verified healthcare professionals globally.
Innovation and technology
- Technology Integration: Combines advanced recruitment technology with industry-specific knowledge to drive project feasibility.
Impact on businesses
- Actionable Insights: Supports pharma clients in gathering data that improves global patient outcomes.
Why it may fit your brief
M3 is a strong choice when standard compliance and verified professional access are the baseline requirements. Other providers may offer more specialized AI-driven tools for specific analysis needs.
Global Vox Populi: best for verified physician and KOL research
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitBest suited for research briefs requiring highly verified physician samples or hard-to-reach KOLs in the United States.
Global Vox Populi operates as an independent primary research partner, providing specialized access to verified healthcare professionals for high-stakes pharmaceutical studies. Its infrastructure in the United States is built around proprietary panels that are directly owned and managed, protecting full control over respondent quality and profiling depth.
The company maintains a focus on rigorous compliance and data integrity, offering a full range of qualitative and quantitative methodologies. By managing its own panels and in-country fieldwork, it provides a stable environment for complex studies requiring precise physician targeting and medical credential validation.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in the United States
174,360 panellists
- Primary & General66,498
- Internal Medicine Subspecialties19,598
- Diagnostic & Laboratory12,588
- Acute, Peri-operative & Critical Care12,588
- Surgical Specialties11,640
- Women's & Reproductive Health11,046
Key opinion leader panel, in the United States
7,707 panellists
- Surgical Specialties1,500
- Internal Medicine Subspecialties1,344
- Diagnostic & Laboratory827
- Public Health & Population560
- Primary & General558
- Nervous System & Mental Health464
Nurses and allied health panel, in the United States
197,240 panellists
- Registered Nurses60,339
- Advanced Practice Nurses15,397
- Licensed / Practical / Enrolled Nurses14,654
- Nursing Support (Aides / HCAs)8,163
- Midwives1,860
- Pharmacists & Pharmacy Techs10,726
Scorecard: 85.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 85.0 |
Core services
- Healthcare Recruitment: Access to healthcare professionals and allied health, along with key opinion leaders.
- Fieldwork Execution: Full-service management of pharma market research studies using internal platforms.
- Qualitative Research: Supporting in-depth interviews and ethnography through expert interviews.
Strengths
- Verified Panel Depth: Owns proprietary panels with 174,360 physicians, 197,240 nurses, and 7,707 KOLs in the United States.
- Rigorous Data Quality: Uses fingerprinting, geo-checks, and trap questions to remove fraudulent completes before data delivery.
- Compliance Expertise: Handles health data under HIPAA and reports adverse events per BHBIA guidance.
Innovation and technology
- Proprietary Platform: In-house survey programming and hosting platform designed for healthcare-specific data requirements.
- Profiling Granularity: Panelists are profiled on 45 to 140 individual data points to support low-incidence targeting.
Impact on businesses
- Strategic Decision Support: Enables pharma brands to optimize commercial performance through accurate physician behavior analysis.
- Clinical Insight Quality: Delivers reliable data that informs patient adherence and product positioning strategies.
Why it may fit your brief
The provider fits well when data integrity and strict adherence to healthcare compliance codes are the priority. Other vendors might be preferred for simple, high-volume consumer health surveys where speed is the only metric.
Sermo: best for peer-to-peer physician community insights
Strongest fitBest for research requiring deep clinical perspective and physician sentiment from an engaged, professional community.
Sermo operates as a medical community for healthcare professionals, providing a platform for clinical discussion and paid research opportunities. Its US physician base is significant, allowing for targeted access to verified practitioners.
The company distinguishes itself by fostering an engaged community where physicians share perspectives on clinical and career challenges, which in turn feeds into its research and engagement solutions.
Scorecard: 83.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 8/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 83.0 |
Core services
- Physician Community: Provides a platform for verified HCPs to connect, discuss cases, and share medical insights.
- Paid Research Surveys: Supports quantitative and qualitative market research among its community members.
- Engagement Solutions: Offers business solutions for pharma to gain insights from the physician network.
Strengths
- Community Engagement: Uses a highly active, peer-to-peer community of physicians for authentic research responses.
- Verified Access: Requires identity and professional credential verification for all community members.
Innovation and technology
- Health Tech Network: Integrates research and engagement within a broader health tech platform reaching over 1.3M HCPs.
Impact on businesses
- Business Transformation: Helps pharma brands work through the lifecycle using direct physician sentiment and engagement.
Why it may fit your brief
Sermo is excellent for projects that benefit from the context of peer-to-peer physician discussions. For studies requiring broad patient or caregiver reach, other providers may be more appropriate.
Ipsos Healthcare: best for global brand health and market tracking
Strongest fitSuited for global pharmaceutical brands requiring longitudinal tracking and strategic market understanding.
Ipsos Healthcare provides research solutions that cover the pharmaceutical lifecycle, from early-stage market strategy to brand health measurement. It uses global reach and specialized teams to deliver insights into physician and patient perceptions.
The company focuses on providing more than data, positioning itself as a partner that translates information into actionable insights for life sciences organizations.
Scorecard: 79.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.5 |
Core services
- Brand Health Tracking: Monitors brand performance and perception among healthcare professionals and patients.
- Market Strategy: Provides strategic market access research to inform competitive positioning.
- Syndicated Research: Offers Global Therapy Monitors to track healthcare system quality and treatment trends.
Strengths
- Strategic Depth: Combines deep therapeutic knowledge with global research expertise to support product lifecycle strategy.
- Global Reach: Maintains large-scale, authenticated panels to support research across multiple international markets.
Innovation and technology
- AI Integration: Uses AI to deliver insights and analyze trends in healthcare trust and system performance.
Impact on businesses
- Smarter Decision Making: Helps clients act faster and more decisively through reliable, actionable research outcomes.
Why it may fit your brief
Ipsos fits well for brand-level, strategic studies that span multiple geographies. Specialized, US-specific tactical studies may find more focused support elsewhere.
Sago: best for hybrid qualitative and quantitative healthcare research
Strongest fitBest for researchers needing a mix of in-person focus groups and online quantitative data collection.
Sago provides comprehensive research services, with a strong focus on healthcare recruitment and facility-based research. It operates a network of physical focus group locations in the United States alongside its digital panel capabilities.
The company supports pharmaceutical clients in brand perception, concept testing, and market segmentation, offering both DIY platforms and fully managed research support.
Scorecard: 79.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | sago.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 8/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | sago.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | sago.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.0 |
Core services
- Healthcare Recruitment: Provides access to diverse HCP and patient audiences for various study types.
- Focus Group Facilities: Operates physical research spaces across multiple US cities for in-person feedback.
- DIY Quant Platform: Offers the Methodify platform for self-serve quantitative research projects.
Strengths
- Hybrid Capabilities: Combines digital reach with physical facilities for a complete range of qualitative and quantitative methods.
- Data Quality Pledge: Maintains rigorous compliance processes and uses SagoVerify to protect data integrity.
Innovation and technology
- AI Research Tools: Uses AI for video summaries, question summaries, and concept extraction to accelerate insight analysis.
Impact on businesses
- Agile Decision Making: Enables faster research cycles, allowing clients to make evidence-based decisions more quickly.
Why it may fit your brief
Sago is a versatile partner for projects that benefit from both digital scale and physical interaction. Purely clinical, remote-only studies might find more focused options with specialized panel-only firms.
Dynata: best for multi-modal data collection at scale
Strongest fitBest for complex research designs requiring multi-modal data collection and high-volume quantitative scale.
Dynata operates a first-party data platform that connects researchers with a vast network of respondents. In the United States, it uses a multi-modal strategy, including online, phone, and SMS, to reach healthcare professionals and patients.
The company emphasizes data quality, using automated tools to identify and remove fraudulent respondents. Its platform-based approach allows for both fully managed projects and self-serve capabilities.
Scorecard: 77.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 9/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 77.5 |
Core services
- Data Platform: Provides access to a first-party data set for survey-based research.
- Multi-Modal Fieldwork: Reaches audiences via web, phone, SMS, and mail to protect representative study designs.
- Brand Lift Measurement: Offers tools to measure advertising impact and brand health among targeted audiences.
Strengths
- Fraud Detection: Uses the QualityScore ML model to analyze 175+ data points and remove fraudulent responses.
- Reach and Flexibility: Combines vast global reach with the ability to target niche healthcare and patient audiences.
Innovation and technology
- AI-Powered Probing: Uses conversational AI to follow up on open-ended questions, providing qualitative depth at scale.
Impact on businesses
- Informed Marketing: Helps businesses optimize marketing spend and content through data-driven audience insights.
Why it may fit your brief
Dynata is a strong partner for quantitative studies where reaching hard-to-find audiences via multiple channels is required. Specialized, purely qualitative clinical studies may prefer smaller, boutique firms.
Toluna: best for AI-enhanced consumer and healthcare insights
Strongest fitIdeal for fast-turnaround quantitative studies requiring rapid consumer or healthcare professional input.
Toluna operates a platform that connects businesses with consumers and healthcare professionals in real-time. It focuses on the on-demand economy, providing insights through proprietary panels and digital survey tools.
The company uses AI to enhance its research services, aiming to provide quick access to data for companies of all sizes.
Scorecard: 73.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Market Presence | 10 | 9/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | toluna.com (2 pages reviewed), Oct 2026 |
| Weighted score | 100 | 73.0 |
Core services
- Digital Research Platform: Provides AI-enhanced tools for conducting on-demand market research.
- HCP Panel Access: Offers a healthcare professional panel validated through ID checks.
- Consumer Insights: Connects businesses with everyday people to capture broad market opinion.
Strengths
- Speed of Insight: Uses digital platforms to deliver research results in the on-demand economy.
- Professional Validation: Uses professional ID checks to protect the validity of its healthcare panel members.
Innovation and technology
- AI-Enhanced Tools: Applies artificial intelligence to speed up research processes and enhance data delivery.
Impact on businesses
- Real-time Decision Making: Enables companies to make informed decisions quickly by engaging with audiences on-demand.
Why it may fit your brief
Toluna works well for projects requiring speed and broad access. Deep, long-form qualitative clinical research may require more specialized, high-touch providers.
Cint: best for agile quantitative data collection
Strongest fitIdeal for quantitative studies requiring rapid turnaround and access to a wide range of respondent profiles.
Cint operates an online research marketplace that aggregates access to diverse respondent groups. It provides the technological infrastructure for researchers to conduct quantitative studies, including those targeting specific healthcare niches.
The company focuses on speed and scale, offering tools for researchers to manage their own projects or work with experts to gather insights from its large network of supply partners.
Scorecard: 66.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | cint.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | cint.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 6/10 | cint.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | cint.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | cint.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | cint.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | cint.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 66.5 |
Core services
- Research Marketplace: Connects researchers to a large network of high-quality respondents for quantitative surveys.
- Agile Data Collection: Supports rapid study deployment for continuous research and market measurement.
- Measurement Tools: Provides ad effectiveness and brand lift measurement solutions.
Strengths
- Marketplace Scale: Accesses a vast network of respondents, allowing for broad or niche audience reach.
- Quality Control: Uses AI, machine learning, and a dedicated team to proactively address industry fraud.
Innovation and technology
- AI-Moderated Interviews: Explores AI-moderated interviews to bridge the gap between qualitative depth and quantitative scale.
Impact on businesses
- Confident Decision Making: Delivers solid data that enables researchers to make business decisions with absolute confidence.
Why it may fit your brief
Cint is a powerful choice for high-volume, quantitative data collection. For deeply specialized, manual clinical research, a boutique provider with dedicated healthcare panels may be better suited.
How HCP credential verification actually works in the United States
Mandate real-time, rolling verification of medical credentials to make sure every participant is an active practitioner.
Professional License Validation
Providers must cross-reference panelist credentials against official government databases, medical registries, and state license records upon registration. In the United States, this includes verifying NPI numbers and board certification status. Ask the provider for proof of their verification frequency. Reliable providers do not rely on self-reported data; they conduct manual or automated checks at enrollment and perform rolling re-validation to make sure that licenses remain active and that the respondent is in good standing with the relevant medical boards.
Ongoing Monitoring Protocols
Credential verification is not a one-time process. A high-quality panel provider continuously monitors for changes in professional status, retirements, or disciplinary actions. When selecting a partner, ask how they handle changes in a physician's practice status or credentials. Good providers update their panel data regularly, making sure that the profile data used for recruitment remains accurate. If a provider cannot describe their re-validation cycle, your study is at risk of including respondents who no longer hold the necessary clinical authority for your research.
Identity Fraud Prevention
Beyond license verification, providers must confirm the identity of the person behind the screen. This involves device fingerprinting, geo-location verification, and sometimes multi-factor authentication for high-value professional respondents. These steps prevent individuals from creating multiple fake accounts or impersonating doctors to access higher-incentive studies. When reviewing proposals, request information on how the provider prevents account sharing or unauthorized access, as these are common methods used to bypass standard verification checks and compromise the integrity of pharmaceutical study results.
Audit-Ready Documentation
For compliance with HIPAA and other research standards, you must be able to audit the recruitment process. Ask the provider if they can supply documentation of the verification performed for each respondent in your sample. A transparent provider maintains a clear, audit-ready trail of how each participant was sourced, verified, and incentivized. If a provider refuses to share their verification methodology or cannot provide evidence of their quality processes, they are likely not meeting the standard required for high-stakes pharmaceutical decision-making in the United States.
How to choose the right provider in the United States
Select a provider based on the specific methodological and compliance requirements of your study, not just on panel size.
- Define Research Objectives: Clearly distinguish between the need for large-scale quantitative data and deep-dive qualitative insights. Choose a provider with a proven track record in your specific required methodology.
- Verify Compliance Protocols: Request a summary of the provider’s HIPAA compliance and adverse event reporting processes. Make sure their internal procedures align with your own corporate governance requirements.
- Assess Recruitment Sources: Prioritize providers that own their proprietary panels over those that rely on open exchanges. This protects higher control over the quality and verification of your target sample.
- Audit Data Quality Tools: Ask for a demonstration of their fraud prevention technology, such as bot detection and straight-lining filters. Confirm that these tools are active during, not after, the fieldwork.
- Request Feasibility Proof: Require a pre-fieldwork feasibility check that accounts for specific physician specialties and geographic requirements. Avoid providers that offer blanket guarantees without reviewing your project criteria.
Questions to ask before you commission
- What is your exact process for verifying physician licenses and board certifications, and how often are these records updated?
- Can you provide a breakdown of your panel recruitment sources, and what percentage of your sample comes from proprietary versus third-party exchanges?
- How do you handle adverse event reporting, and can you walk me through your compliance process for a typical pharmaceutical study?
- What specific technical controls do you have in place to prevent survey fraud, such as automated bot detection and device fingerprinting?
- Are you able to provide a detailed feasibility report that accounts for our specific therapeutic area and physician specialty requirements?
- How does your team manage data quality during fieldwork to make sure that poor-quality completes are removed before the final delivery?
Common pitfalls to avoid
- Relying on Open Exchanges: Using providers that aggregate sample from multiple unknown sources increases the risk of fraudulent data and inconsistent respondent quality.
- Ignoring Compliance Audits: Failing to verify a provider’s HIPAA and regulatory adherence can lead to significant legal and ethical complications for your pharma research project.
- Overlooking Profile Granularity: Assuming a large panel size equates to high-quality targeting for niche specialties often leads to poor feasibility and high screen-out rates.
- Neglecting Real-Time Monitoring: Waiting until the end of the project to review data quality results in unusable datasets and wasted budget on fraudulent completes.
What a feasibility check should include
Require a documented feasibility check that specifically evaluates the target audience against your project’s required incidence and profiling variables.
Specialty-Specific Incidence
A proper check must confirm the number of active, reachable physicians within the exact specialty or sub-specialty required for the study. This makes sure the sample is attainable within your project timeline.
Geographic and Practice Filters
The feasibility check should account for geographic distribution and practice settings, such as hospital versus private practice, to make sure the resulting data reflects the target population.
Profiling Depth Verification
Confirm that the provider has existing data points on the required sample, such as prescribing volume or patient load, to minimize the need for lengthy screening questions.
Incentive and Engagement Review
The assessment should include a review of the proposed honoraria to make sure it aligns with fair market value and is sufficient to engage the target audience effectively.
Conclusion
Choosing an HCP panel provider in the United States is a strategic decision that directly impacts the validity of your pharmaceutical research. For large-scale tracking and commercial strategy, providers with deep, integrated datasets such as IQVIA offer an advantage, while specialized, high-touch research firms like Global Vox Populi and Sermo provide the granular verification and qualitative focus necessary for clinical and physician-specific insights.
Use the provided scorecard to evaluate each provider against your specific project needs. Prioritize firms that demonstrate ownership of their proprietary panels and provide transparent, audit-ready documentation of their compliance and verification processes. By focusing on respondent quality, data integrity, and methodological flexibility, you can make sure that your research delivers the evidence required to make confident, strategic decisions in the highly regulated pharmaceutical sector.
Planning research in the United States? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
How to verify healthcare professional panel quality?
Verification requires checking that the provider uses proprietary panels rather than open exchanges. You should request evidence of their license validation processes, such as NPI checks and board certification confirmation. A reliable provider will allow you to audit these procedures and will provide documentation on how they handle respondent credentialing, re-validation cycles, and identity confirmation to prevent fraudulent participation.
What are the best HCP panels for pharmaceutical market research?
The best panels are those that specialize in healthcare and maintain high standards for credential verification. Global Vox Populi, M3 Global Research, and Sermo are recognized for their focus on verified physician communities. IQVIA is notable for integrating survey data with large-scale clinical and pharmacy datasets, while Dynata and Sago offer extensive reach and methodological diversity for complex research designs.
How do you protect HIPAA compliance in pharma market research?
HIPAA compliance in market research is protected by implementing strict data de-identification protocols and securing all participant information. Providers must have documented processes for handling protected health information, including encryption, access controls, and clear data retention policies. You should require your research partner to confirm their HIPAA-compliant infrastructure and provide a data protection agreement that outlines their specific responsibilities for safeguarding sensitive respondent information.
Difference between HCP panels and physician social networks?
HCP panels are primarily designed for market research, with recruitment focused on survey participation and data collection. Physician social networks, such as Sermo, support community interaction, peer-to-peer discussion, and clinical knowledge exchange. While social networks can be used for market research, they are fundamentally built for professional connection. Research-dedicated panels are generally more focused on the methodological requirements of survey-based data collection.
How to reach high-prescribing physicians for surveys?
Reaching high-prescribing physicians requires providers with deep profiling data. Look for partners that track prescribing habits or have access to relevant pharmacy data. A well-profiled panel will allow for precise targeting based on specific therapeutic areas or patient volumes. You must clearly define your prescribing criteria during the project scoping phase to make sure the provider can filter their panel effectively to match your specific requirements.
What is the cost of HCP market research panels?
The cost of HCP research varies significantly based on the rarity of the specialty, the length of the survey, and the complexity of the research design. Generally, high-incidence specialties are more cost-effective, while rare-disease specialists or high-prescribing KOLs command higher honoraria. Most providers operate on a per-project quote basis. It is essential to request a transparent breakdown of costs, including recruitment, fieldwork, and data processing fees.
Are HCP panels reliable for quantitative pharmaceutical research?
HCP panels are reliable for quantitative research provided they are properly verified and managed. Reliability depends on the provider’s use of proprietary panels, ongoing credential checks, and sophisticated fraud detection tools. When panels are built on verified, first-party data and monitored for quality, they provide consistent and representative insights that are appropriate for strategic pharmaceutical decision-making in the United States.
What are the most common pitfalls when buying HCP research?
Common pitfalls include relying on providers that use open sample exchanges, neglecting to audit the verification process, and failing to define clear quality standards before fieldwork begins. Other mistakes include underestimating the complexity of low-incidence targeting and ignoring the necessity of real-time fraud monitoring. Always make sure your research partner provides transparent documentation of their recruitment and quality controls to avoid these risks.